Equine Encephalitis Pipeline Review H2 2014

Equine Encephalitis Pipeline Review, H2 2014 By RnRMarketResearch

Browse more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals ÂŠ http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Equine Encephalitis Pipeline Review, H2 2014 Global Markets Direct’s, ‘Equine Encephalitis Pipeline Review, H2 2014′, provides an overview of the Equine Encephalitis’s therapeutic pipeline. Equine Encephalitis is a rare but serious viral disease spread by mosquitoes that can affect people and horses. In the United States, approximately 5-10 EE cases are reported yearly. People of all ages are at risk for infection with it. Severe cases of Equine Encephalitis infection begin with the sudden onset of headache, high fever, chills, and vomiting. It takes 4-10 days after the bite of an infected mosquito to develop symptoms. The viral reservoir varies depending on climate and habitat changes and often exhibits an annual fluctuation between avirulent and virulent strains. Complete report available at http://www.rnrmarketresearch.com/equineencephalitis-pipeline-review-h2-2014-market-report.html .

Equine Encephalitis Pipeline Review, H2 2014 This report provides comprehensive information on the therapeutic development for Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Equine Encephalitis and special features on late-stage and discontinued projects. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

ÂŠ http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Equine Encephalitis Pipeline Review, H2 2014 Scope: • The report provides a snapshot of the global therapeutic landscape of Equine Encephalitis. • The report reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. • The report reviews key players involved in the therapeutics development for Equine Encephalitis and enlists all their major and minor projects. • The report summarizes all the dormant and discontinued pipeline projects.

Equine Encephalitis Pipeline Review, H2 2014 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies. • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. • Develop strategic initiatives by understanding the focus areas of leading companies. • Identify and understand important and diverse types of therapeutics under development for Equine Encephalitis.

Equine Encephalitis Pipeline Review, H2 2014

For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441

RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.

ÂŠ http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Turn static files into dynamic content formats.

Create a flipbook